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Molecular Adsorbent Recirculating System (MARS) is a extracorporeal liver 
support which uses albumin to remove low molecular weight toxins in patients with 
liver diseases(1). Patient blood is dialyzed across an albumin-impregnated membrane 
against 20% albumin. This albumin solution recalculates in a closed-circuit that 
includes Charcoal (AC) and strong anion exchange (SAX) resin columns for albumin 
regeneration.
In this work we analyzed peptides and proteins absorbed into the SAX-MARS resin 
column after the treatment in patients with resistant pruritus of chronic cholestasis. As 
commercial albumin used for dialysis already contains other residual proteins, a control 
sample was prepared recirculating 20% commercial albumin through a MARS SAX 
resin column for six hours. Proteins bound to the SAX cartridge were extracted using a 
stepwise gradient of salt and acetonitrile. Protein extracts were digested by trypsin and 
GluC. Digested peptides were analyzed by multidimensional liquid chromatography 
coupled to tandem mass spectrometry (MDLC/MS/MS) using a linear LTQ ion trap 
equipped with a microESI ion source. MS/MS fragmentation spectra were searched 
using SEQUEST search engine against the Human UniProt database.
With this method a total of 146 different proteins were identified to be absorbed by 
the SAX resin column. Forty three proteins were observed only after patient treatments 
while the rest where already present in the MARS-albumin. Presence of some of these 
tentative patient-derived proteins was confirmed by Liquid Chromatography and 
Multiple Reaction Monitoring focusing on the precursor and product ions corresponding 
to target peptides(2). By using this methodology, five proteins have been confirmed to 
be dialyzed from patients (Neutrophil Defensin 1, Secreted Ly-6/uPAR-related protein 
1(SLUR1), Serum Amyloid A, Fibrinogen Alpha Chain and Pancreatic prohormone 
precursor). Among these, the presence of Neutrophil Defensin 1 and SLUR1 has also 
been validated by western blotting.
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